Retraction
miR-133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion
Paper Information
Record ID:
52781
Author(s):
Journal:
Publication Date:
November 16, 2017
Retraction Date:
February 26, 2024
(1.7 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ol.2024.14308Additional Notes:
see also: https://pubpeer.com/publications/F801E09E27A3E4669E792ACBC75489
Citations (20)
20
Total Citations4
Post-Retraction(20.0%)
16
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
4
Within 1 year
0
After 2+ years
304
Days since retraction (latest)
Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells
Yaman Alghamian, Chadi Soukkarieh, Abdulmunim Aljapawe et al. (4 authors)
Biochemistry and Biophysics Reports
Published: Dec 2024
304 days after retraction
The Oncolytic Effect of Aerva lanata on Osteosarcoma Cell Lines via the Apoptotic Signaling Pathway
Ummu Zuvairiya, S Menaka, Selvaraj Jayaraman et al. (4 authors)
Cureus
Open Access
Published: Apr 2024
1 citation
1 citation
46 days after retraction
Retraction: Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6
Unknown Authors
PLoS ONE
Open Access
Published: Mar 2024
29 days after retraction
Retraction: Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells
Unknown Authors
PLoS ONE
Open Access
Published: Mar 2024
1 citation
1 citation
29 days after retraction
MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma
Meysam Moghbeli
Pathology - Research and Practice
Open Access
Published: Aug 2023
10 citations
10 citations
204 days before retraction
miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses
Ahmed S. Doghish, Mohammed S. Elballal, Ola Elazazy et al. (14 authors)
Pathology - Research and Practice
Published: Apr 2023
55 citations
55 citations
326 days before retraction
The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review
Victoria L. Tippett, Luke Tattersall, Norain Ab. Latif et al. (6 authors)
Oncogene
Open Access
Published: Nov 2022
16 citations
16 citations
458 days before retraction
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS <i>in vitro</i> by targeting RUNX2
Zhengxiang Huang, Lintuo Huang, Lue Liu et al. (8 authors)
Journal of Chemotherapy
Published: Mar 2021
7 citations
7 citations
1068 days before retraction
Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis
Weitong Zhang, Zhenfen Wang, Guohao Cai et al. (4 authors)
Cancer Management and Research
Open Access
Published: Mar 2021
28 citations
28 citations
1092 days before retraction
Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
Zhaopeng Tang, Yubao Lu, Yutong Chen et al. (6 authors)
Technology in Cancer Research & Treatment
Open Access
Published: Jan 2021
14 citations
14 citations
1151 days before retraction
MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
Chenyang Meng, Zhenqun Zhao, Rui Bai et al. (9 authors)
Molecular Medicine Reports
Open Access
Published: Aug 2020
22 citations
22 citations
1285 days before retraction
miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells
Mohammadreza Bazavar, Jafar Fazli, Amir Valizadeh et al. (10 authors)
Pathology - Research and Practice
Published: Aug 2020
30 citations
30 citations
1290 days before retraction
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System
Dominik A. Barth, Jaroslav Juráček, Ondřej Slabý et al. (5 authors)
Cancers
Open Access
Published: Aug 2020
39 citations
39 citations
1302 days before retraction
TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma
Ke Zhang, Hong Zhou, Bo Yan et al. (4 authors)
Cancer Cell International
Open Access
Published: May 2020
24 citations
24 citations
1391 days before retraction
Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies
Miguel Pereira‐Silva, Carmen Alvarez‐Lorenzo, Angel Concheiro et al. (6 authors)
European Journal of Pharmaceutics and Biopharmaceutics
Published: Jan 2020
25 citations
25 citations
1501 days before retraction
Advances in the role of miRNAs in the occurrence and development of osteosarcoma
Guanyu Zhang, Yiran Li, Jiasheng Xu et al. (4 authors)
Open Medicine
Open Access
Published: Jan 2020
4 citations
4 citations
1517 days before retraction
Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
Xiaohong Yin, Yinghui Jin, Yue Cao et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Aug 2019
52 citations
52 citations
1664 days before retraction
P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma
Chao He, Zhenyu Sun, Robert M. Hoffman et al. (7 authors)
Anticancer Research
Open Access
Published: Apr 2019
58 citations
58 citations
1792 days before retraction
miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma
G.F. Gao, Zhen Tian, Huan-Ye Zhu et al. (4 authors)
Cancer Cell International
Open Access
Published: Dec 2018
28 citations
28 citations
1913 days before retraction
MicroRNA‑504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
Xin Chen, Chen Lv, Xiongbai Zhu et al. (8 authors)
Oncology Letters
Open Access
Published: Nov 2018
23 citations
23 citations
1922 days before retraction
Quick Stats
Total Citations:
20
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025